DERMATOMYOSITIS SINE MYOSITIS

Clinical trials for DERMATOMYOSITIS SINE MYOSITIS explained in plain language.

Never miss a new study

Get alerted when new DERMATOMYOSITIS SINE MYOSITIS trials appear

Sign up with your email to follow new studies for DERMATOMYOSITIS SINE MYOSITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Experimental drug trial targets deadly autoimmune lung attack

Disease control Not yet recruiting

This small, early-stage study is testing if a drug called Emapalumab can help control a severe, fast-worsening lung disease linked to a specific immune system antibody (anti-MDA5). The drug, already used for another serious immune condition, will be given to 5 adults to see if it…

Matched conditions: DERMATOMYOSITIS SINE MYOSITIS

Phase: PHASE2 • Sponsor: University of Miami • Aim: Disease control

Last updated Apr 01, 2026 14:43 UTC

DERMATOMYOSITIS SINE MYOSITIS

Get alerted when new DERMATOMYOSITIS SINE MYOSITIS trials appear

Experimental drug trial targets deadly autoimmune lung attack